搜索
Vir Biotechnology Inc
VIR添加自选
10.160USD
+0.590+6.17%
收盘 06/23, 16:00（美东）报价延迟15分钟
1.71B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
8.35%
SB Investment Advisers (UK) Limited
7.78%
ARCH Venture Partners
7.66%
Vanguard Portfolio Management, LLC
5.46%
GSK plc
5.07%
其他
65.68%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
8.35%
SB Investment Advisers (UK) Limited
7.78%
ARCH Venture Partners
7.66%
Vanguard Portfolio Management, LLC
5.46%
GSK plc
5.07%
其他
65.68%
股东类型
持股股东
占比
Investment Advisor
27.80%
Investment Advisor/Hedge Fund
14.04%
Private Equity
9.19%
Venture Capital
8.00%
Hedge Fund
5.85%
Corporation
5.07%
Research Firm
3.25%
Individual Investor
1.50%
Foundation
0.92%
其他
24.39%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
497
130.35M
77.29%
+9.59M
2025Q4
484
108.68M
78.12%
-13.10M
2025Q3
481
113.05M
81.28%
-6.82M
2025Q2
530
124.85M
89.88%
-15.28M
2025Q1
571
125.80M
91.30%
-16.44M
2024Q4
568
122.14M
89.06%
-13.83M
2024Q3
554
118.76M
86.83%
-17.44M
2024Q2
572
119.53M
87.47%
-20.55M
2024Q1
564
122.68M
91.07%
-16.10M
2023Q4
577
121.87M
90.75%
-16.40M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
14.08M
8.81%
+357.12K
+2.60%
Dec 31, 2025
SB Investment Advisers (UK) Limited
13.12M
8.21%
-1.34M
-9.28%
Dec 31, 2025
ARCH Venture Partners
12.92M
8.08%
--
--
Feb 27, 2026
GSK plc
8.55M
5.35%
--
--
Dec 31, 2025
State Street Investment Management (US)
6.23M
3.9%
+988.26K
+18.86%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.54M
1.59%
-442.59K
-14.86%
Dec 31, 2025
OrbiMed Advisors, LLC
2.38M
1.49%
--
--
Dec 31, 2025
Geode Capital Management, L.L.C.
2.33M
1.46%
+81.98K
+3.65%
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Genomics Immunology and Healthcare ETF
1.13%
Virtus LifeSci Biotech Clinical Trials ETF
0.77%
Invesco NASDAQ Future Gen 200 ETF
0.65%
Global X Genomics & Biotechnology ETF
0.59%
Invesco S&P SmallCap Health Care ETF
0.34%
ALPS Medical Breakthroughs ETF
0.34%
Hypatia Women CEO ETF
0.27%
State Street SPDR S&P Biotech ETF
0.2%
ProShares Ultra Nasdaq Biotechnology
0.11%
Direxion Daily S&P Biotech Bull 3X Shares
0.1%
查看更多
iShares Genomics Immunology and Healthcare ETF
占比1.13%
Virtus LifeSci Biotech Clinical Trials ETF
占比0.77%
Invesco NASDAQ Future Gen 200 ETF
占比0.65%
Global X Genomics & Biotechnology ETF
占比0.59%
Invesco S&P SmallCap Health Care ETF
占比0.34%
ALPS Medical Breakthroughs ETF
占比0.34%
Hypatia Women CEO ETF
占比0.27%
State Street SPDR S&P Biotech ETF
占比0.2%
ProShares Ultra Nasdaq Biotechnology
占比0.11%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.1%
